Table 1. Summary of the search strategy.

Item	Specification
Date of search	October 1, 2023 to February 1, 2024
Databases and other sources searched	PubMed, Web of Science, Elsevier, and ClinicalTrials.gov
Search terms used	NSCLC, oligometastatic, advanced, EGFR, TKI, SBRT, SABR, RT, and local consolidative therapy
Timeframe	From January 2009 to February 2024
Inclusion and exclusion criteria	Inclusion criteria: English-language articles; randomized controlled trials, prospective or retrospective cohort studies, case reports or series, case-control studies and translational preclinical studies
	Exclusion criteria: non-English language articles; editorial comments, abstracts, conference materials, review articles, guidelines, consensus statements, and study protocols
Selection process	Study selection and full-text articles were assessed by X.Z. and S.Z.

NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor; SBRT, stereotactic body radiation therapy; SABR, stereotactic ablative radiotherapy; RT, radiotherapy.